Clinical trial · Interventional
Fear of Recurrence and Stopping Immunotherapy
Distress Associated With Stopping Immunotherapy of Cancer Patients
NCT04761328CI-TRIAL-00098526recruitingN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The study includes participants experiencing distress with regard to stopping immunotherapy and will utilize cognitive-behavioral therapy to reduce fear of recurrence, depression, and anxiety and improve quality of life.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Cognitive Behavioral Therapy | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| cognitive behavioral therapy | Behavioral | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- EXPERIMENTAL
- label
- Cessation of treatment
- description
- If the patient is randomized to this arm, they will be asked to stop their immunotherapy
- interventionNames
- Behavioral: cognitive behavioral therapy
Primary outcomes (1)
- measure
- Reduce fear of recurrence
- timeFrame
- 3 months
- description
- Change by 50%
Secondary outcomes (3)
- measure
- Improve quality of life
- timeFrame
- 3 months
- description
- Change of quality of life by 5 points
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 21 Years
Show eligibility criteria text
Inclusion Criteria: * Age 21 years and older * Fluent in English * Diagnosis of cancer and history of treatment with immunotherapy Exclusion Criteria: * Active suicidal ideation, delusions or hallucinations
References
Publications (0)
Data not yet available
No reference posted for this study.